s6y

Basel Medical Group Ltd

Ticker
BMGL
CIK
2004489
Industry
Services-Offices & Clinics of Doctors of Medicine

Financials 1

  1. NT 20-F Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F for period ending Jun 30, 2025

Ownership 10

  1. 3 Initial statement of beneficial ownership of securities
  2. 3 Initial statement of beneficial ownership of securities
  3. 3 Initial statement of beneficial ownership of securities
  4. 3 Initial statement of beneficial ownership of securities
  5. 3 Initial statement of beneficial ownership of securities
  6. 3 Initial statement of beneficial ownership of securities
  7. 3 Initial statement of beneficial ownership of securities
  8. 3 Initial statement of beneficial ownership of securities
  9. 3 Initial statement of beneficial ownership of securities
  10. 3 Initial statement of beneficial ownership of securities

Prospectus 15

  1. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  2. DRS Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
  3. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  4. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  5. FWP Filing under Securities Act Rules 163/433 of free writing prospectuses
  6. DRS/A Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
  7. DRSLTR Correspondence Related to Draft Registration Statement
  8. DRSLTR Correspondence Related to Draft Registration Statement
  9. DRS/A Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
  10. DRSLTR Correspondence Related to Draft Registration Statement

All 15 prospectus filings

Other 58

  1. 20-F Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
  2. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  3. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  4. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  5. EFFECT Notice of Effectiveness
  6. F-1/A Registration statement for securities of certain foreign private issuers
  7. F-1 Registration statement for securities of certain foreign private issuers
  8. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  9. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  10. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

All 58 other filings